ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
34 announcements with these filters
Novelix Pharmaceuticals reported a total annual revenue of ₹132.34 Crore and net profit of ₹2.56 Crore for FY26. The results received an unmodified audit opinion.
Novelix Pharmaceuticals approved audited FY2026 financial results and received ₹0.42 Crore from warrant conversions. Revenue reached ₹132.34 Crore with a net profit of ₹2.56 Crore.
Novelix Pharmaceuticals declared non-applicability of the Annual Secretarial Compliance Report for FY2026. The company remains exempt due to being below SEBI LODR regulatory thresholds.
Novelix Pharmaceuticals scheduled a board meeting on May 29, 2026, to approve audited financial results and warrant conversions. Investors should track post-meeting outcomes for strategic updates.